Breast Cancer Clinical Trial

Mobile Behavior Change Program for Weight Loss in Breast Cancer Survivors

Summary

The purpose of this study is to evaluate the preliminary efficacy of a Noom Breast Cancer Weight Loss Program on weight loss outcomes, quality of life, and physical activity. Also, to qualitatively determine acceptability of this novel program among breast cancer survivors with overweight or obesity.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Able to understand and provide informed consent
18 years and older
Overweight or obesity (BMI ≥ 27.5)
Not 6 months postpartum
Not planning to become pregnant in the next 7 months
Have a smartphone that is compatible with Noom's mobile app
Breast cancer survivor with stage I, II, or III
Completed active treatment (e.g, surgery, chemo, radiation, etc.) > 6 months ago

Exclusion Criteria:

Inability or unwillingness of a participant to give written informed consent
Currently pregnant or < 6 months postpartum
Plans to become pregnant within the next 7 months
Stage IV, metastatic cancer or DCIS
Currently taking insulin
Uncontrolled hypertension

Study is for people with:

Breast Cancer

Estimated Enrollment:

30

Study ID:

NCT04753268

Recruitment Status:

Completed

Sponsor:

Noom Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Noom, Inc
New York New York, 10001, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

30

Study ID:

NCT04753268

Recruitment Status:

Completed

Sponsor:


Noom Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.